Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
13F holders, Q2 2026
Institutional positions in Aspire Biopharma Holdings, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −2 vs. Q1 2026
- Shares held
- 47.0K
- −331.6K (−87.6%) vs. Q1 2026
- Total value
- $250.9K
- −$121.1K (−32.6%) vs. Q1 2026
- New holders
- 2
- 3 more added
- Sold out
- 4
- 8 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $250.9K |
| Q1 2026 | 15 | $371.9K |
| Q4 2025 | 30 | $899.8K |
| Q3 2025 | 25 | $645.6K |
| Q2 2025 | 16 | $544.7K |
| Q1 2025 | 15 | $875.8K |
| Q4 2024 | 3 | $5.36M |
| Q3 2024 | 2 | $149.6K |
| Q2 2024 | 3 | $90.4K |
| Q1 2024 | 19 | $18.1M |
| Q4 2023 | 21 | $17.9M |
| Q3 2023 | 21 | $18.2M |
| Q2 2023 | 14 | $17.0M |
| Q1 2023 | 59 | $267.9M |
| Q4 2022 | 57 | $264.7M |
| Q3 2022 | 61 | $260.8M |
| Q2 2022 | 54 | $243.4M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 14,830 | $79.2K | 0.00% | +14,830 | New |
| Geode Capital Management, LLC | 10,474 | $55.9K | 0.00% | −32,910−75.9% | Reduced |
| Vanguard Capital Management LLC | 10,408 | $55.6K | 0.00% | +2,549+32.4% | Added |
| Vanguard Fiduciary Trust Co | 10,081 | $53.8K | 0.00% | +7,225+253.0% | Added |
| Crewe Advisors LLC | 677 | $3.62K | 0.00% | −19,658−96.7% | Reduced |
| Tower Research Capital LLC (TRC) | 283 | $1.51K | 0.00% | −1,891−87.0% | Reduced |
| Toronto Dominion Bank | 166 | $886 | 0.00% | −4,834−96.7% | Reduced |
| Hallmark Capital Management Inc | 33 | $176 | 0.00% | −967−96.7% | Reduced |
| Crossingbridge Advisors, LLC | 20 | $107 | 0.00% | −24,328−99.9% | Reduced |
| SBI Securities Co., Ltd. | 2 | $11 | 0.00% | +1+100.0% | Added |
| UBS Group AG | 1 | $5 | 0.00% | −191,498−100.0% | Reduced |
| Barclays PLC | 1 | $5 | 0.00% | +1 | New |
| Avion Wealth | 45 | $0 | 0.00% | −1,307−96.7% | Reduced |
| Morgan Stanley | 0 | $0 | 0.00% | −76,955−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,846−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |